TauRx Therapeutics Selects BioClinica For eClinical And Imaging Solutions
<0> Company:Jim Dorsey, 267-757-3040orTrade Media:Beth Nestlerode, 484-342-3600orInvestors:Michael Porter, 212-564-4700orFinancial Media:Bill Gordon, 212-564-4700 </0>
BioClinica, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that TauRx Therapeutics has signed agreements with BioClinica to use Trident IWR/IVR and Imaging Core Lab (ICL) solutions to support its upcoming Phase III clinical trials. TauRx, a Singapore-based company, focuses its research on therapies and diagnostics for the treatment of Alzheimer's disease and other neurodegenerative disorders. With primary research facilities in Aberdeen in the United Kingdom, TauRx is the latest European customer to select BioClinica for both Imaging and eClinical offerings.
TauRx has selected Trident IWR/IVR for a series of expanded trials for its pipeline of neurology treatment candidates. “TauRx chose Trident IWR to reduce the lead time and effort needed to prepare for our studies, while supporting all of our randomization and clinical supplies tracking requirements,” said Dr. Jiri Hardlund, Chief Medical Officer for TauRx. “When we investigated the available technologies, it was clear that Trident offered clear advantages for our trials’ requirements.”
A separate selection team evaluated imaging solutions, and also selected BioClinica for its Imaging Core Lab solutions for processing MRI data. “MRI imaging represents a critical eligibility and safety component of our clinical studies,” said Dr. Diane Downie, Global Logistics and Support Lead at TauRx. “Our MRI imaging partner needed to understand the unique requirements of our pioneering scientific research. BioClinica’s MRI imaging solution best matched all of our requirements.”
BioClinica’s Imaging Core Lab uses innovative technology to efficiently acquire, process, and read medical images. With more than 22 years of world-wide experience, the team brings the scientific knowledge to make that technology work for sponsors of any size. With a highly-regarded medical affairs team and deep roster of collaborative consultants, BioClinica provides the imaging expertise necessary to ensure the highest quality clinical trial outcomes.
"BioClinica is clearly a technology leader for clinical trial applications,” said Peter Benton, BioClinica's eClinical Solutions President. “While great technology is essential, our business model also offers a fresh approach for clinical trial support -- one that makes it faster and more cost-efficient than other alternatives, whether the sponsor is large or small. Combined with our global reach, experience and customer support, we believe no other solution matches BioClinica for value or performance.”
Follow BioClinica on the Trial Blazers blog at , and on twitter at .
TauRx Therapeutics is a clinical stage pharmaceutical company focused on the discovery of Tau Protein Aggregation Inhibitors and other novel therapies and diagnostics for the treatment of Alzheimer's disease (AD) and other neurodegenerative disorders. TauRx is developing drugs to treat the underlying pathology of AD, to modify or halt disease progression or to prevent it entirely. TauRx Therapeutics is headquartered in Singapore with primary research facilities in Aberdeen, Scotland. For more information please visit .
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica solutions maximize efficiency and manageability throughout all phases of the clinical trial process. With over 22 years of experience and more than 2,500 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit .